The Truth Emerges On July 29, 2025, Novo issued a press release and held a conference call lowering its sales and profit outlook for 2025, citing "lowered growth expectations for the second half of 2025" for both Wegovy and Ozempic due to "the persistent use of compounded GLP-1s, slower-than-expected market expansion and competition." Management also noted that despite the expiry of the FDA grace period for mass compounding on May 22, 2025, company research showed that unsafe and unlawful mass compounding continued
Reta GLP-3 (24 mg) is a novel peptide designed to support weight management and metabolic health
@Easyderm EasyDerm_Partner #pimple #pimplepatch #pimplepop #acnepatch #acneproneskin This is giving kindergarten vibes and so stupid I keep seeing people walking around with bright, star-shaped pimple patches right in the middle of their face, and I honestly dont understand when this became a thing we all agreed was cute
Support for Chronic Illnesses: Some clinics use IV glutathione as part of supportive care for neurodegenerative, autoimmune, or inflammatory conditions
United States IGFDES is not FDA-approved for medical or therapeutic use Legal to possess and purchase for research use only (RUO) Illegal to sell, market, or label for human consumption This places it in the same legal category as BPC157, CJC1295, and other common performance-enhancing peptides sold online
